Biodesy LLC
This article was originally published in Start Up
Executive Summary
Second-harmonic generation is an optical phenomenon that occurs when a nonlinear surface combines photons of light to produce photons with twice the frequency and half the wavelength of the original photons. Biodesy is harnessing its power to measure protein conformation for drug discovery.
You may also be interested in...
Start-Up Biodesy Developing Tools To Enable Researchers To See Protein Shape Changes In Real Time
California biotech, which recently raised a $15 million Series A financing, is developing second harmonic generation technology that can capture high-resolution movies of proteins as their shapes and functions change. This could help researchers determine which molecules might work at specific binding sites.
Start-Up Previews (5/07)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group: In Inflammation, the Indication's the Thing, features profiles of Anthera Pharmaceuticals, Logical Therapeutics, Opsona Therapeutics and VLST Corp.. Plus these Start-Ups Across Health Care: Biodesy, Magenta Medical and NuLens.
In Inflammation, the Indication's the Thing
With a host of drugs on the market for large inflammatory disease indications like rheumatoid arthritis, start-ups are finding niches elsewhere.